These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 1656889)

  • 21. PML-RAR alpha fusion transcripts by RNA PCR in acute promyelocytic leukemia in remission and its correlation with clinical outcome.
    Ikeda K; Sasaki K; Tasaka T; Nagai M; Kawanishi K; Takahara J; Irino S
    Int J Hematol; 1994 Oct; 60(3):197-205. PubMed ID: 7858239
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A new complex translocation t(5;17;15)(q11;q21;q22) in acute promyelocytic leukemia.
    Abe S; Ishikawa I; Harigae H; Sugawara T
    Cancer Genet Cytogenet; 2008 Jul; 184(1):44-7. PubMed ID: 18558288
    [TBL] [Abstract][Full Text] [Related]  

  • 23. All-trans-retinoic acid in acute promyelocytic leukemia and its potential in other hematologic malignancies.
    Tallman MS
    Semin Hematol; 1994 Oct; 31(4 Suppl 5):38-48. PubMed ID: 7831584
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Acute promyelocytic leukemia. New methods in diagnosis and treatment.
    Varghese L; Janckila A; Yam LT
    J Ky Med Assoc; 1999 Feb; 97(2):61-5. PubMed ID: 10073058
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Structure, localization and transcriptional properties of two classes of retinoic acid receptor alpha fusion proteins in acute promyelocytic leukemia (APL): structural similarities with a new family of oncoproteins.
    Kastner P; Perez A; Lutz Y; Rochette-Egly C; Gaub MP; Durand B; Lanotte M; Berger R; Chambon P
    EMBO J; 1992 Feb; 11(2):629-42. PubMed ID: 1311253
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A retinoid acid 'resistant' t(15;17) acute promyelocytic leukemia cell line: isolation, morphological, immunological, and molecular features.
    Duprez E; Ruchaud S; Houge G; Martin-Thouvenin V; Valensi F; Kastner P; Berger R; Lanotte M
    Leukemia; 1992 Dec; 6(12):1281-7. PubMed ID: 1453773
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Induction of retinoid resistance by all-trans retinoic acid in acute promyelocytic leukemia after remission.
    Cornic M; Chomienne C
    Leuk Lymphoma; 1995 Jul; 18(3-4):249-57. PubMed ID: 8535190
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Molecular monitoring of the myl/retinoic acid receptor-alpha fusion gene in acute promyelocytic leukemia by polymerase chain reaction.
    Biondi A; Rambaldi A; Pandolfi PP; Rossi V; Giudici G; Alcalay M; Lo Coco F; Diverio D; Pogliani EM; Lanzi EM
    Blood; 1992 Jul; 80(2):492-7. PubMed ID: 1320955
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Retinoids and their nuclear receptors.
    Hashimoto Y; Shudo K
    Cell Biol Rev; 1991; 25(3):209-30, 233-5. PubMed ID: 1364328
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Retinobenzoic acids and nuclear retinoic acid receptors.
    Hashimoto Y
    Cell Struct Funct; 1991 Apr; 16(2):113-23. PubMed ID: 1650290
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The t(15;17) breakpoint in acute promyelocytic leukemia cluster within two different sites of the myl gene: targets for the detection of minimal residual disease by the polymerase chain reaction.
    Chang KS; Lu JF; Wang G; Trujillo JM; Estey E; Cork A; Chu DT; Freireich EJ; Stass SA
    Blood; 1992 Feb; 79(3):554-8. PubMed ID: 1310060
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Retinoids--"differentiation agents" for cancer treatment and prevention.
    Hofmann SL
    Am J Med Sci; 1992 Sep; 304(3):202-13. PubMed ID: 1335685
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Acute promyelocytic leukemia.
    Warrell RP; de Thé H; Wang ZY; Degos L
    N Engl J Med; 1993 Jul; 329(3):177-89. PubMed ID: 8515790
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Frequent rearrangements of retinoic acid receptor alpha gene and myl gene, and rare mutations of RAS and FMS genes in acute promyelocytic leukemia.
    Yamamoto K; Hirosawa S; Sakamaki H; Aoki N
    Am J Hematol; 1992 Aug; 40(4):252-8. PubMed ID: 1323928
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pathogenesis and management of acute promyelocytic leukemia.
    Warrell RP
    Annu Rev Med; 1996; 47():555-65. PubMed ID: 8712802
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A variant t(14;17) in acute promyelocytic leukemia. Positive response to retinoic acid treatment.
    Cigudosa JC; Calasanz MJ; Odero MD; Marín J; Bengoechea E; Gullón A
    Cancer Genet Cytogenet; 1995 Apr; 80(2):160-1. PubMed ID: 7736436
    [TBL] [Abstract][Full Text] [Related]  

  • 37. RAR-alpha gene rearrangements as a genetic marker for diagnosis and monitoring in acute promyelocytic leukemia.
    Biondi A; Rambaldi A; Alcalay M; Pandolfi PP; Lo Coco F; Diverio D; Rossi V; Mencarelli A; Longo L; Zangrilli D
    Blood; 1991 Apr; 77(7):1418-22. PubMed ID: 1849030
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Molecular genetics of acute promyelocytic leukemia.
    Lin RJ; Egan DA; Evans RM
    Trends Genet; 1999 May; 15(5):179-84. PubMed ID: 10322484
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Retinoid therapy for autoimmune diseases].
    Fukasawa H; Kagechika H; Shudo K
    Nihon Rinsho Meneki Gakkai Kaishi; 2006 Jun; 29(3):114-26. PubMed ID: 16819260
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Transcriptional regulation by the nuclear receptor superfamily.
    Yu VC; Näär AM; Rosenfeld MG
    Curr Opin Biotechnol; 1992 Dec; 3(6):597-602. PubMed ID: 1369415
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.